Blocking Sphingolipids Counteracts Muscular Dystrophy

In a new study, the group of Johan Auwerx, PhD, at École Polytechnique Fédérale de Lausanne’s (EPFL’s) School of Life Sciences has made the first connection between muscular dystrophy and sphingolipids, a group of bioactive lipids. The study was published online on January 28, 2022 in Science Advances. The open-access article is titled “Inhibition of Sphingolipid De Novo Synthesis Counteracts Muscular Dystrophy.”
Login Or Register To Read Full Story